The following were the most common treatment-related AEs of any grade in the participants: increased ALT concentration in 14 (48.3%), increased AST concentration in 13 (44.8%), and hyperlipemia in 13 (44.8%), nausea in 7 (24.1%), proteinuria in 7 (24.1%), decreased appetite in 7 (24.1%), rash (7 [24.1%]), diarrhea in 6 (20.7%), and asthenia in 6 (20.7%). Here, GPT is linked to asthenia.